109 related articles for article (PubMed ID: 17634397)
41. Concerted actions of NHERF2 and WNK4 in regulating TRPV5.
Jing H; Na T; Zhang W; Wu G; Liu C; Peng JB
Biochem Biophys Res Commun; 2011 Jan; 404(4):979-84. PubMed ID: 21187068
[TBL] [Abstract][Full Text] [Related]
42. Molecular physiology of the WNK kinases.
Kahle KT; Ring AM; Lifton RP
Annu Rev Physiol; 2008; 70():329-55. PubMed ID: 17961084
[TBL] [Abstract][Full Text] [Related]
43. Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature.
Park HW; Kim JY; Choi SK; Lee YH; Zeng W; Kim KH; Muallem S; Lee MG
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10750-5. PubMed ID: 21670282
[TBL] [Abstract][Full Text] [Related]
44. WNK4 kinase stimulates caveola-mediated endocytosis of TRPV5 amplifying the dynamic range of regulation of the channel by protein kinase C.
Cha SK; Huang CL
J Biol Chem; 2010 Feb; 285(9):6604-11. PubMed ID: 20061383
[TBL] [Abstract][Full Text] [Related]
45. WNK4 kinase negatively regulates the surface expression of muscarinic M3 receptor.
Chung WY; Park HW; Heo DK; Kim KH; Lee MG; Kim JY
Cell Signal; 2011 Mar; 23(3):566-71. PubMed ID: 21118716
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of human WNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells.
Ohta A; Yang SS; Rai T; Chiga M; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2006 Oct; 349(2):804-8. PubMed ID: 16949040
[TBL] [Abstract][Full Text] [Related]
47. Phosphoregulation of K
Frenette-Cotton R; Marcoux AA; Garneau AP; Noel M; Isenring P
J Cell Physiol; 2018 Jan; 233(1):396-408. PubMed ID: 28276587
[TBL] [Abstract][Full Text] [Related]
48. The acidic motif of WNK4 is crucial for its interaction with the K channel ROMK.
Murthy M; Cope G; O'Shaughnessy KM
Biochem Biophys Res Commun; 2008 Oct; 375(4):651-4. PubMed ID: 18755144
[TBL] [Abstract][Full Text] [Related]
49. Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation.
Mayan H; Mouallem M; Shaharabany M; Pauzner R; Farfel Z
Am J Obstet Gynecol; 2005 Feb; 192(2):598-603. PubMed ID: 15696009
[TBL] [Abstract][Full Text] [Related]
50. WNK protein kinases modulate cellular Cl- flux by altering the phosphorylation state of the Na-K-Cl and K-Cl cotransporters.
Kahle KT; Rinehart J; Ring A; Gimenez I; Gamba G; Hebert SC; Lifton RP
Physiology (Bethesda); 2006 Oct; 21():326-35. PubMed ID: 16990453
[TBL] [Abstract][Full Text] [Related]
51. WNK4 limits distal calcium losses following acute furosemide treatment.
Ferdaus MZ; Gratreak BDK; Miller L; Si J; McCormick JA; Yang CL; Ellison DH; Terker AS
Physiol Rep; 2019 Sep; 7(17):e14195. PubMed ID: 31496133
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of WNK1 in POMC-expressing neurons reduces weigh gain via WNK4-mediated degradation of Kir6.2.
Chung WY; Han JW; Heo W; Lee MG; Kim JY
Mol Cell Biochem; 2018 Oct; 447(1-2):165-174. PubMed ID: 29392534
[TBL] [Abstract][Full Text] [Related]
53. Syndromes of impaired ion handling in the distal nephron: pseudohypoaldosteronism and familial hyperkalemic hypertension.
Kostakis ID; Cholidou KG; Perrea D
Hormones (Athens); 2012; 11(1):31-53. PubMed ID: 22450343
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylation of KLHL3 at serine 433 impairs its interaction with the acidic motif of WNK4: a molecular dynamics study.
Wang L; Peng JB
Protein Sci; 2017 Feb; 26(2):163-173. PubMed ID: 27727489
[TBL] [Abstract][Full Text] [Related]
55. WNK4 phosphorylates ser(206) of claudin-7 and promotes paracellular Cl(-) permeability.
Tatum R; Zhang Y; Lu Q; Kim K; Jeansonne BG; Chen YH
FEBS Lett; 2007 Aug; 581(20):3887-91. PubMed ID: 17651736
[TBL] [Abstract][Full Text] [Related]
56. [Expression of WNK4 gene regulated by aldosterone].
You T; Zhao Y; Qiu G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):297-300. PubMed ID: 23744318
[TBL] [Abstract][Full Text] [Related]
57. Ste20-type kinases: evolutionarily conserved regulators of ion transport and cell volume.
Strange K; Denton J; Nehrke K
Physiology (Bethesda); 2006 Feb; 21():61-8. PubMed ID: 16443823
[TBL] [Abstract][Full Text] [Related]
58. TRPV4: a new target for the hypertension-related kinases WNK1 and WNK4.
Gamba G
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1303-4. PubMed ID: 16467131
[No Abstract] [Full Text] [Related]
59. The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension.
Hureaux M; Mazurkiewicz S; Boccio V; Vargas-Poussou R; Jeunemaitre X
Kidney Int Rep; 2021 Oct; 6(10):2639-2652. PubMed ID: 34622103
[TBL] [Abstract][Full Text] [Related]
60. A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190.
Glover M; Sweeny C; Davis B; O'Shaughnessy KM
Open Med Chem J; 2010 Sep; 4():57-61. PubMed ID: 21249167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
